Pharmaids Pharmaceuticals Ltd Stock Analysis

BSE: 524572 | NSE: | Trading | Small Cap

BSE Share Price Jan 25, 18:01
15.40 0.05 (0.33%)

DeciZen - Make an Informed Decision on Pharmaids Pharma

M-Cap below 100cr DeciZen not available


1. Is Pharmaids Pharmaceuticals Ltd a good quality company?

Data is not available for this company.

2. Is Pharmaids Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Pharmaids Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Pharmaids Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Pharmaids Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Pharmaids Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
ROCE % 2.2%2.1%-14.6%-3.1%-19.8%-14%-31.2%-3.8%0.4%1.1%-
Value Creation Index -0.8-0.9-2.0-1.2-2.4-2.0-3.2-1.3-1.0-0.9-

Growth Parameters

Growth Parameters Colour Code Guide
YoY Gr. Rt. %-2.4%11%22.7%-2.9%-28.6%-62.5%24.4%-100%NA-
Adj EPS 0.10.2-1-0.2-1.2-0.8-1.1-
YoY Gr. Rt. %-36.4%-793.3%NANANANANANA200%-
BVPS (₹)
Adj Net Profit 00.1-0.4-0.1-0.4-0.3-0.4-0.200.10
Cash Flow from Ops.
Debt/CF from Ops.


CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 23.9%38.5%166.8%NA
Adj EPS -2.2%NANA200%
Share Price 22% 31.2% 48.4% 27.8%

Key Financial Parameters

Performance Ratio Colour Code Guide
Return on Equity % 1.82.4-17.8-3.7-26.2-18.5-31.2-
Op. Profit Mgn % 10.95.9-31.1-5.3-20.5-28.6-86-
Net Profit Mgn % 34-25.2-3.8-23.6-21.1-85.9-31.601.11.6
Debt to Equity
Working Cap Days 6936695844243854701,0032,9550334445
Cash Conv. Cycle 37039332220520921435934503241

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.60%

Sales growth is growing at healthy rate in last 3 years 166.84%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -20.63%

Latest Financials - Pharmaids Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 8.2 -
BVPS (₹.) 8.4 -
Reserves (₹ Cr.) -2 -
P/BV 1.84 -
PE 117.62 -
From the Market
52 Week Low / High (₹) 9.76 / 30.40
All Time Low / High (₹) 1.00 / 43.00
Market Cap (₹ Cr.) 15.9
Equity (₹ Cr.) 10.3
Face Value (₹) 10
Industry PE 77.6

Management X-Ray of Pharmaids Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes


About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited Incorporated in the year 1989 at Hyderabad (Telangana, India). The company is suppliers of Quality Grade range of Specialty chemicals, Skin care, Hospital care and Generic products in the areas of Orthopedic, Neuro and Gastro etc. Its technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygienic standards. Its professionals strive to offer best quality and high purity to attain maximum client's satisfaction. The company’s offered product range is highly acknowledged in the market for its precise composition long shelf life, hygienic processing techniques, premium quality and high purity.

Business area of the company

The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.


  • Speciality Chemicals
  • Skin Care Products
  • Hospital Care Products
  • Generics
Read More Read Less